Global Metabolic Partnering Report 2022: Deal Trends, Players and Financials Analysis of 1100+ Deals Signed Since 2015 – ResearchAndMarkets.com -…

DUBLIN--(BUSINESS WIRE)--The "Global Metabolic Partnering 2015-2022: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering. Global Metabolic Partnering 2015 to 2022 provides the full collection of 1100+ Metabolic disease deals signed between the world's pharmaceutical and biotechnology companies since 2015. Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology.

Genexine Announces Dosing of First Patient in Phase 2 clinical trial with Triple Combination Therapy in Patients with Head and Neck Squamous Cell…

SEOUL, South Korea--(BUSINESS WIRE)--Genexine (KOSDAQ: 095700), a publicly traded, clinical-staged Korean biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of unmet medical needs, today announced the dosing of the first patient in phase 2 clinical trial using triple combination therapy in patients with recurrent/metastatic HNSCC. The combination therapy consists of two of Genexines proprietary drugs, GX-188E (a first-in-class therapeutic DNA vaccine), GX-I7 (a first-in-class long-acting interleukin 7), and OpdivoR (nivolumab), a marketed PD-1 immune checkpoint inhibitor

Make these changes to your diet to say goodbye to acne – Health shots

Acne is a persistent skin inflammation problem which most commonly affects the face, sometimes the shoulders, back, neck, chest, or upper arms too and results in patches and pimples. Although it can happen at any age, it frequently happens during puberty when the sebaceous glands are active. Although it is not harmful, it may leave skin scars

Snyder Institute researchers discover new approach to healing skin infections and wounds – EurekAlert

image:Rachel Kratofil view more Credit: Rachel Kratofil University of Calgary researchershave identified a promising new approach to treating bacterial skin infections.In astudy recently published inNature,first author Dr. Rachel Kratofil, PhD, and co-senior authors Drs. Paul Kubes, PhD, Justin Deniset, PhD, and their research team show new insight which could lead to advancements in treating bacterial infections and wounds

Sure Signs You Have Liver Disease, Say Physicians Eat This Not That – Eat This, Not That

Liverdisease can be very sneakyif people don't know the signs, it can be easy to miss until the disease is advanced. "That's the tough part of treatment," says Anurag Maheshwari, MD, a gastroenterologist with the Institute for Digestive Health and Liver Disease at Mercy Medical Center in Baltimore. "Convincing patients that they need to act now in order to avoid complications in the future can sometimes be a challenge, because they don't feel any different today." Here are five sure signs of liver disease, according to doctors.